Usage of standardized tomato extract in practice – AD 2019 state of art Reprint from: Medycyna Faktów 2019; 1(42): 13-18.

Abstract

Inhibiting the ability of thrombocytes to aggregate is one of the basic directions of pharmacotherapy of the cardiovascular diseases. The use of classical antiplatelet drugs, however, is associated with the risk of bleeding complications. Recent studies have shown that the benefits of using acetylsalicylic acid outweigh the risks only in the case of a confirmed cardiovascular disease. In many other situations – in patients with diabetes, hypertension, obesity, with high cardiovascular risk – safe inhibition of platelet activity would also be very valuable. This possibility is potentially created by standardized extract from tomato seeds. This article summarizes current knowledge about the properties of STE and its applicability in practice.